Franklin Lakes, New Jersey-based Becton, Dickinson and Company (BDX) is a global medical technology company that develops, ...

Matt Miksic from Barclays lowered the price target on Becton, Dickinson, and Company (NYSE:BDX) from $261 to $241, while ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

The latest price target for Becton Dickinson (NYSE:BDX) was reported by Barclays on June 3, 2025. The analyst firm set a price target for $241.00 expecting BDX to rise to within 12 months (a ...

In this article, we are going to take a look at where Becton, Dickinson, and Company (NYSE:BDX) stands against other best falling stocks to buy according to analysts. Over the past two years ...

Becton, Dickinson and Company (BDX) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings. Skip to content Home ...

In this article, we are going to take a look at where Becton, Dickinson and Company (NYSE:BDX) stands against the other oversold stocks. Due to the uncertainty surrounding the tariff news ...

BDX has dropped 25% since May 2024 vs. S&P 500’s 6% and MedTech’ Becton Dickinson's organic growth outlook cut to ~3–4%, down from ~5–6% two years ago. Ready to turn the market’s ...

BECTON, DICKINSON ($BDX) posted quarterly earnings results on Thursday, May 1st. The company reported earnings of $3.35 per share, beating estimates of $3.31 by $0.04 ...

This was the stock's second consecutive day of losses.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...